Max Healthcare Q4 FY26: PAT up 3% to Rs 387cr, Rs 2 dividend

What Max Healthcare reported for Q4 FY26

Max Healthcare Institute Ltd reported a 3 percent year-on-year rise in network profit after tax (PAT) to Rs 387 crore for the quarter ended March 31, 2026. The company had posted a network PAT of Rs 376 crore in the corresponding quarter of the previous fiscal. The update matters because it captures operating trends at a large listed hospital chain at a time when the sector is adding capacity through both brownfield and greenfield projects. Management also used the results to outline the near-term ramp-up plan for ongoing expansions and the timeline for a new hospital in Lucknow. The company said it has delivered 22 consecutive quarters of year-on-year growth, keeping the focus on steady execution rather than one-off gains. Alongside earnings, the board announced both a dividend recommendation and a large capital expenditure decision.

Revenue growth stayed at 10 percent in the March quarter

The company said gross revenue in Q4 FY26 stood at Rs 2,664 crore, up 10 percent over the same period of the previous fiscal. Revenue growth was accompanied by stable utilisation, with bed occupancy reported at 75 percent for the quarter. Occupied bed days (OBDs) increased 8 percent year-on-year, indicating volume growth even as the occupancy rate remained unchanged at the reported level. Average revenue per occupied bed (ARPOB) in Q4 FY26 was Rs 77,900 compared with Rs 77,100 in Q4 FY25, pointing to a modest improvement in realisations. Together, these metrics suggest growth came from a combination of higher patient throughput and slightly better pricing or case mix. The company did not provide a break-up of revenue by geography or specialty in the provided update. Still, the revenue and utilisation numbers offer a snapshot of demand and capacity use during the quarter.

Profit performance and what changed year-on-year

Network PAT increased to Rs 387 crore in Q4 FY26 from Rs 376 crore in Q4 FY25. The increase is smaller than the revenue growth rate for the quarter, which can happen when costs move differently from realisations or when newer facilities dilute margins during ramp-up phases. However, the company did not provide cost-line details or margins for Q4 FY26 in the provided statement. What is clear is that the profit growth was positive and consistent with the company’s broader narrative of consecutive quarters of year-on-year expansion. Management linked the performance to continuing growth in the network and the scaling up of capacity additions. Investors typically track how quickly expansions translate into higher occupied bed days and stable ARPOB. In this quarter, OBDs and ARPOB both moved up year-on-year, supporting the reported profit increase.

Board actions: final dividend and large capex approval

Max Healthcare said its board of directors recommended a final dividend of Rs 2 per equity share of face value Rs 10 for FY26. Separately, the board approved an investment of Rs 1,400 crore for construction of a 712-bed greenfield hospital at Shaheed Path, Lucknow. The Lucknow project was positioned as a response to growing demand for quality healthcare services in Uttar Pradesh. The company said the new hospital will be spread across 5 acres and is expected to be commissioned in FY30. It will be Max Healthcare’s second hospital in Lucknow. These decisions indicate that the company is balancing shareholder payouts with long-gestation expansion plans.

FY26 performance: revenue crossed Rs 10,500 crore

For the financial year ended March 31, 2026, network gross revenue stood at Rs 10,538 crore. Network PAT after exceptional items was reported at Rs 1,631 crore in FY26, compared with Rs 1,336 crore in FY25, a 22 percent increase. The FY26 numbers show that earnings growth outpaced revenue growth at the full-year level, based on the figures provided. Management highlighted that the network has delivered 22 consecutive quarters of year-on-year growth, and specifically said revenue increased 10 percent. The company’s annual profitability figure is important for tracking cash generation potential and reinvestment capacity as it pursues multi-year hospital projects. In hospital businesses, profits and cash flows can vary by ramp-up stages of new units, so investors often watch the gap between near-term quarterly growth and longer-term annual growth.

Expansion pipeline: brownfield ramps and a Gurgaon greenfield

CMD Abhay Soi said the company has commenced phased commissioning and ramp-up of brownfield expansions across Mohali, Mumbai and Delhi, representing approximately 20 percent capacity addition. Brownfield additions typically add beds and infrastructure within or adjacent to existing hospitals, and may scale faster because the operating ecosystem is already in place. The company also said it expects to augment capacity by another 10 percent with the commissioning of the greenfield Gurgaon facility by the end of the year. These timelines, if executed as described, imply a notable step-up in bed capacity across regions where Max Healthcare already operates. For investors, the near-term question generally becomes how quickly the additional capacity translates into higher occupancy and OBDs without pressuring ARPOB.

Why Lucknow is a multi-year bet

The Lucknow hospital is planned as a 712-bed greenfield facility, expected to be commissioned in FY30. That makes it a longer-horizon project relative to brownfield ramps in Mohali, Mumbai and Delhi. Greenfield hospitals usually require time for construction, regulatory readiness, staffing, and gradual patient acquisition. The company’s decision to invest Rs 1,400 crore suggests it is planning for sustained demand growth beyond its current network footprint. Because it will be the company’s second hospital in Lucknow, the strategy also implies a desire to deepen presence in an existing city rather than entering a completely new market. The timeline gives the company room to synchronise the Lucknow build-out with near-term capacity additions elsewhere.

Key numbers at a glance

Market impact: what investors typically track next

The immediate datapoints from the update are revenue growth, stable occupancy at 75 percent, and the increase in ARPOB to Rs 77,900. The capacity addition plan is also central, with about 20 percent capacity addition linked to brownfield expansions across Mohali, Mumbai and Delhi, and a further 10 percent expected from the Gurgaon greenfield commissioning by end of year. In hospital operators, large capacity expansions can temporarily affect profitability while utilisation builds, even if demand is healthy. The Lucknow capex decision is material because it is large at Rs 1,400 crore and its commissioning is expected in FY30, meaning the investment cycle extends across multiple years. Dividend recommendation of Rs 2 per share signals the board’s willingness to return cash even while committing to new projects.

Conclusion

Max Healthcare’s Q4 FY26 update showed a 3 percent rise in network PAT to Rs 387 crore on 10 percent revenue growth to Rs 2,664 crore, alongside stable 75 percent occupancy and a higher ARPOB. The board recommended a final dividend of Rs 2 per share for FY26 and approved Rs 1,400 crore to build a 712-bed Lucknow hospital expected to be commissioned in FY30. Management also flagged phased commissioning of brownfield expansions across Mohali, Mumbai and Delhi and expects the Gurgaon greenfield facility to be commissioned by end of year. The next set of updates investors are likely to watch will be the pace of ramp-up in the expanded facilities and the milestones disclosed for the Lucknow project.